Family Firm Inc. Raises Position in iShares Nasdaq Biotechnology ETF (IBB)

Family Firm Inc. boosted its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 1.3% in the 1st quarter, Holdings Channel reports. The firm owned 7,600 shares of the financial services provider’s stock after acquiring an additional 101 shares during the quarter. Family Firm Inc.’s holdings in iShares Nasdaq Biotechnology ETF were worth $850,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Ellis Investment Partners LLC lifted its stake in iShares Nasdaq Biotechnology ETF by 10,590.0% in the 1st quarter. Ellis Investment Partners LLC now owns 1,761,815 shares of the financial services provider’s stock valued at $1,761,000 after purchasing an additional 1,745,334 shares during the last quarter. Deutsche Bank AG raised its stake in shares of iShares Nasdaq Biotechnology ETF by 32,925.6% during the fourth quarter. Deutsche Bank AG now owns 1,683,314 shares of the financial services provider’s stock valued at $162,320,000 after acquiring an additional 1,678,217 shares during the last quarter. State of Tennessee Treasury Department bought a new position in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter valued at $40,732,000. Lockheed Martin Investment Management Co. raised its stake in shares of iShares Nasdaq Biotechnology ETF by 173.9% during the fourth quarter. Lockheed Martin Investment Management Co. now owns 417,400 shares of the financial services provider’s stock valued at $40,250,000 after acquiring an additional 265,000 shares during the last quarter. Finally, Main Management LLC raised its stake in shares of iShares Nasdaq Biotechnology ETF by 14.2% during the fourth quarter. Main Management LLC now owns 398,987 shares of the financial services provider’s stock valued at $38,474,000 after acquiring an additional 49,514 shares during the last quarter. 67.92% of the stock is owned by institutional investors and hedge funds.

Shares of IBB stock traded up $0.48 during trading hours on Wednesday, hitting $102.92. 17,652 shares of the company’s stock traded hands, compared to its average volume of 3,192,054. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.

TRADEMARK VIOLATION WARNING: “Family Firm Inc. Raises Position in iShares Nasdaq Biotechnology ETF (IBB)” was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2019/05/15/family-firm-inc-raises-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: How Important is Technical Analysis of Stocks

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit